Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: an article on the 10Q

"... to have now paved the way for future licensing activity and operating returns commensurate with the portfolio's broad applicability in the digital marketplace ..."

This 10Q ending at the end of August came as no surprise regarding the numbers.

The only surprise is the lack of revenue in the "Subsequent Events" section:
Can it be that Acer and Amazon haven't paid yet (but didn't the settlement dictate it immediately after the ITC decisioin?)?

At least they bought back nearly half million shares in September/October.

GLTA

Share
New Message
Please login to post a reply